We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Yanks Approval for Sun Pharma Seizure Drug Due to Issues at India Site
FDA Yanks Approval for Sun Pharma Seizure Drug Due to Issues at India Site
The FDA has revoked its March approval of Sun Pharma’s Elepsia XR antiseizure medication, citing manufacturing quality problems at the Halol, India, facility where the drug is produced.